Literature DB >> 89502

Effect of irradiation on thyroid-autoantibody production.

A M McGregor, S M McLachlan, B R Smith, R Hall.   

Abstract

Irradiated lymphocytes have been found to stimulate thyroid-autoantibody synthesis by lymphocyte cultures. It is proposed that a similar effect is involved in the increased autoimmune response which follows radioiodine treatment for Graves' disease.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 89502     DOI： 10.1016/s0140-6736(79)91494-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  7 in total

1.  Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies.

Authors:  F Latrofa; D Ricci; L Montanelli; P Piaggi; B Mazzi; F Bianchi; F Brozzi; P Santini; E Fiore; M Marinò; M Tonacchera; P Vitti
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

2.  Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.

Authors:  C Regalbuto; S Salamone; C Scollo; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 3.  131I-Induced Graves' disease in patients treated for toxic multinodular goitre: systematic review and descriptive analysis.

Authors:  C Roque; C A Vasconcelos
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

Review 4.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

5.  The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease.

Authors:  Ola Lindgren; Pernilla Asp; Anna Sundlöv; Jan Tennvall; Bushra Shahida; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2019-01-03

6.  Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres.

Authors:  Bushra Shahida; Kleoniki Tsoumani; Tereza Planck; Vijayachitra Modhukur; Pernilla Asp; Anna Sundlöv; Jan Tennvall; Peter Åsman; Ola Lindgren; Mikael Lantz
Journal:  Endocrine       Date:  2021-12-02       Impact factor: 3.633

7.  The role of thyrotrophin receptor antibody assays in graves' disease.

Authors:  C Kamath; M A Adlan; L D Premawardhana
Journal:  J Thyroid Res       Date:  2012-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.